Literature DB >> 38383

Ventricular tachycardia in a patient on dehydroemetine and chloroquine for amoebic liver abscess.

M S Seshadri, L John, K Varkey, T S Koshy.   

Abstract

A case of ventricular tachycardia in patient who was being treated with dehydroemetine and chloroquine for amoebic liver abscess is reported. The patient had 15 episodes of this arrhythmia. The hazard of using dehydroemetine and chloroquine in conventional doses, even sequentially, is emphasized.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38383     DOI: 10.5694/j.1326-5377.1979.tb127000.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Syncope in a patient being treated for hepatic and intestinal amoebiasis.

Authors:  Kavita Yelve; Sanat Phatak; Meenakshi Amit Patil; Amar R Pazare
Journal:  BMJ Case Rep       Date:  2012-11-30

Review 2.  Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths.

Authors:  Shivraj Padiyar; Debashish Danda
Journal:  Eur J Rheumatol       Date:  2020-10-08

Review 3.  Cardiac and arrhythmic complications in patients with COVID-19.

Authors:  Adriano Nunes Kochi; Ana Paula Tagliari; Giovanni Battista Forleo; Gaetano Michele Fassini; Claudio Tondo
Journal:  J Cardiovasc Electrophysiol       Date:  2020-04-13

4.  Assessment of Cardiac Arrhythmic Risk in Children With Covid-19 Infection.

Authors:  İbrahim Ece; Mücahit Koçoğlu; Ahmet Vedat Kavurt; Denizhan Bağrul; A Esin Kibar Gül; Serhat Koca; İbrahim İlker Çetin; A Nur Özkaya Parlakay; Sevcan Aksoy
Journal:  Pediatr Cardiol       Date:  2020-10-02       Impact factor: 1.655

5.  Disease Severity Affects Ventricular Repolarization Parameters in Patients With COVID-19.

Authors:  Mevlut Koc; Hilmi Erdem Sumbul; Erdinc Gulumsek; Hasan Koca; Yurdaer Bulut; Emre Karakoc; Tuba Turunc; Edip Bayrak; Huseyin Ali Ozturk; Muhammed Zubeyir Aslan; Abdullah Orhan Demirtas; Yahya Kemal Icen
Journal:  Arq Bras Cardiol       Date:  2020-11       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.